FrancophonIA/ELRC3.0 huggingface dataset:
English: Kidney and body weights were reduced in males as was the incidence of renal cytoplasmic vacuolisation.
Croatian: U mužjaka je došlo do smanjenja težine bubrega i tjelesne težine, kao i pojavljivanja bubrežne vakuolizacije citoplazme.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains trientine tetrahydrochloride equivalent to 150 mg trientine.
Croatian: 2. KVALITATIVNI I KVANTITATIVNI SASTAV Jedna filmom obložena tableta sadrži trientintetraklorid što odgovara 150 mg trientina.
English: Each film-coated tablet (tablet) contains trientine tetrahydrochloride equivalent to 150 mg trientine.
Croatian: Jedna filmom obložena tableta (tableta) sadrži trientintetraklorid koji odgovara količini od 150 mg trientina.
English: Hematopoietic cell proliferation was seen in the spleen of males.
Croatian: U slezeni mužjaka primijećena je proliferacija hematopoetskih stanica.
English: Manufacturer Delpharm Evreux 5 rue du Guesclin
Croatian: Proizvođač Delpharm Evreux 5 rue du Guesclin 27000 Evreux Francuska
English: There is limited information in patients with renal impairment.
Croatian: Za bolesnike s oštećenjem funkcije bubrega podaci su ograničeni.
English: If you take more Cuprior than you should
Croatian: Ako uzmete više lijeka Cuprior nego što ste trebali Cuprior uzimajte samo kako je propisan.
English: The scored filmcoated tablet can be divided in two equal halves, if required, to provide a more precise dose or facilitate administration.
Croatian: Prema potrebi se, radi preciznijeg doziranja ili lakše primjene, filmom obložena tableta s urezom može razdijeliti u dvije jednake polovice.
English: Positive results for sensitization potential in Guinea pig maximization tests were reported.
Croatian: U testovima maksimizacije na zamorcima zabilježeni su pozitivni rezultati u pogledu senzibilizirajućeg potencijala.
English: CLINICAL PARTICULARS
Croatian: 4. KLINIČKI PODATCI
English: Mannitol.
Croatian: - mučnina
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains trientine tetrahydrochloride equivalent to 150 mg trientine.
Croatian: 2. NAVOĐENJE DJELATNE(IH) TVARI Jedna filmom obložena tableta sadrži trientintetraklorid što odgovara 150 mg trientina.
English: Posology
Croatian: Nuspojave
English: Iron oxide yellow (E172).
Croatian: Film ovojnica: poli(vinilni alkohol) talk titanijev dioksid (E171) glicerolkaprilokaprat (vrsta I) žuti željezov oksid (E172) natrijev laurilsulfat
English: Tablet film-coating:
Croatian: Filmom obložena tableta
English: PHARMACEUTICAL FORM
Croatian: 4. FARMACEUTSKI OBLIK I SADRŽAJ
English: Colloidal anhydrous silica.
Croatian: Jezgra tablete: manitol bezvodni koloidni silicijev dioksid gliceroldibehenat
English: - stomach upsets and discomfort, including severe stomach pains (duodenitis)
Croatian: - nadražaj i nelagoda u trbuhu, uključujući jaku bol u trbuhu (duodenitis) - upala crijeva koja može dovesti do npr. boli u trbuhu, ponavljajućeg proljeva i krvi u stolici
English: Strength Pharmaceutical Form Route of administration Packaging Content (concentration) Package size
Croatian: Doza Farmaceutski oblik
English: This summary was last updated in 06-2016.
Croatian: Sažetak je posljednji put ažuriran u 06.2016.
English: It is available as tablets (0.088, 0.18, 0.35, 0.7 and 1.1 mg).
Croatian: Dostupan je u obliku tableta (od 0,088 mg, 0,18 mg, 0,35 mg, 0,7 mg i 1,1 mg).
English: The dose should be increased every five to seven days until symptoms are controlled without causing side effects that cannot be tolerated.
Croatian: Dozu je potrebno povećavati svakih pet do sedam dana sve dok se ne postigne kontrola nad simptomima, a da pritom ne dođe do pojave nuspojava koje bolesnik ne može podnositi.
English: Pramipexole Accord EMA/403892/2016
Croatian: Pramipeksol Accord EMA/403892/2016
English: The full EPAR for Pramipexole Accord can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Croatian: Cjeloviti EPAR za lijek Pramipeksol Accord nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: The starting dose is one 0.088 mg tablet three times a day.
Croatian: Početna je doza jedna tableta od 0,088 mg tri puta dnevno.
English: This means that Pramipexole Accord is similar to a ‘reference medicine' already authorised in the European Union (EU) called Mirapexin.
Croatian: To znači da je lijek Pramipeksol Accord sličan „referentnom lijeku” koji je već odobren u Europskoj uniji (EU) pod nazivom Mirapexin.
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Pramipexole Accord.
Croatian: Objašnjava kako je Odbor za lijekove za humanu uporabu (CHMP) ocijenio lijek da bi donio svoje mišljenje u korist izdavanja odobrenja za stavljanje lijeka u promet te preporuke o uvjetima za primjenu lijeka Pramipeksol Accord.
English: Pramipexole stimulates the brain as dopamine would, so that patients can control their movement and have fewer of the signs and symptoms of Parkinson's disease, such as shaking, stiffness and slowness of movement.
Croatian: Pramipeksol stimulira mozak poput dopamina kako bi bolesnici mogli kontrolirati pokrete i imali manje znakova i simptoma Parkinsonove bolesti kao što su tresavica, ukočenost i usporenost pokreta.
English: For more information about treatment with Pramipexole Accord, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Croatian: Više informacija o liječenju lijekom Pramipeksol Accord pročitajte u uputi o lijeku (također dio EPAR-a), odnosno obratite se svom liječniku ili ljekarniku.
English: What measures are being taken to ensure the safe and effective use of Pramipexole Accord?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Pramipeksol Accord?
English: Pramipexole Accord can be used either on its own or in combination with levodopa (another medicine for Parkinson's disease), at any stage of disease including the later stages when levodopa starts becoming less effective.
Croatian: Lijek Pramipeksol Accord može se primjenjivati kao monoterapija ili u kombinaciji s levodopom (drugi lijek za liječenje Parkinsonove bolesti) u bilo kojoj fazi bolesti, uključujući u uznapredovalim fazama u kojima levodopa gubi na djelotvornosti.
English: In patients with Parkinson's disease, the cells that produce dopamine begin to die and the amount of dopamine in the brain decreases.
Croatian: U bolesnika s Parkinsonovom bolešću stanice koje proizvode dopamin počinju odumirati i stoga se količina dopamina u mozgu smanjuje.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Pramipexole Accord have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Pramipeksol Accord nalaze se u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: What are the benefits and risks of Pramipexole Accord?
Croatian: Koje su koristi i rizici od lijeka Pramipeksol Accord?
English: The maximum daily dose is three 1.1 mg tablets.
Croatian: Tri tablete od 1,1 mg najveća su dopuštena dnevna doza.
English: Pramipexole Accord is used to treat the symptoms of Parkinson's disease, a progressive brain disorder that causes shaking, slow movement and muscle stiffness.
Croatian: Lijek Pramipeksol Accord koristi se za liječenje simptoma Parkinsonove bolesti, progresivnog moždanog poremećaja koji uzrokuje tresavicu, usporene pokrete i ukočenost mišića.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pramipexole Accord on 30 September 2011.
Croatian: Europska komisija izdala je odobrenje za stavljanje lijeka Pramipeksol Accord u promet koje vrijedi na području Europske unije od 30. rujna 2011.
English: Because Pramipexole Accord is a generic medicine and is bioequivalent to the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Croatian: Budući da je lijek Pramipeksol Accord generički lijek i da je bioekvivalentan referentnom lijeku, smatra se da su njegovi koristi i rizici isti kao i oni referentnog lijeka.
English: Other information about Pramipexole Accord
Croatian: Ostale informacije o lijeku Pramipeksol Accord
English: The active substance in Pramipexole Accord, pramipexole, is a dopamine agonist (a substance that imitates the action of dopamine).
Croatian: Djelatna tvar u lijeku Pramipeksol Accord, pramipeksol, agonist je dopamina (tvar koja imitira djelovanje dopamina).
English: Dopamine is a messenger substance in the parts of the brain that control movement and co-ordination.
Croatian: Dopamin je tvar koja prenosi živčane impulse u dijelovima mozga koji kontroliraju kretnju i koordinaciju.
English: Pramipexole Accord is a ‘generic medicine'.
Croatian: Lijek Pramipeksol Accord je „generički lijek”.
English: Pramipexole Accord pramipexole
Croatian: Pramipeksol Accord pramipeksol
English: Pramipexole Accord must be given less often in patients who have problems with their kidneys.
Croatian: Lijek Pramipeksol Accord mora se primjenjivati rjeđe u bolesnika koji imaju problema s bubrezima.
English: If treatment is stopped for any reason, the dose should be decreased gradually.
Croatian: Potrebno je postupno smanjivati dozu u slučaju prekida liječenja.
English: The CHMP concluded that, in accordance with EU requirements, Pramipexole Accord has been shown to have comparable quality and to be bioequivalent to Mirapexin.
Croatian: Odbor za lijekove za humanu uporabu (CHMP) zaključio je kako je, u skladu sa zahtjevima EU-a, dokazano da lijek Pramipeksol Accord ima usporedivu kakvoću i da je bioekvivalentan lijeku Mirapexin.
English: This is a summary of the European public assessment report (EPAR) for Pramipexole Accord.
Croatian: Ovo je sažetak europskoga javnog izvješća o ocjeni dokumentacije o lijeku (EPAR) Pramipeksol Accord.
English: Pramipexole Accord is a medicine that contains the active substance pramipexole.
Croatian: Pramipeksol Accord je lijek koji sadrži djelatnu tvar pramipeksol.
English: Because Pramipexole Accord is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicine, Mirapexin.
Croatian: Budući da je lijek Pramipeksol Accord generički lijek, ispitivanja na ljudima bila su ograničena na utvrđivanje činjenice je li lijek bioekvivalentan referentnom lijeku Mirapexin.
English: The Committee recommended that Pramipexole Accord be given marketing authorisation.
Croatian: Odbor je preporučio davanje odobrenja za stavljanje lijeka Pramipeksol Accord u promet u EU-u.
English: Therefore, the CHMP's view was that, as for Mirapexin, the benefit outweighs the identified risk.
Croatian: Stoga je stav CHMP-a da korist nadmašuje identificirani rizik, kao i za Mirapexin.
English: Why has Pramipexole Accord been approved?
Croatian: Zašto je lijek Pramipeksol Accord odobren?
English: How does Pramipexole Accord work?
Croatian: Kako djeluje Pramipeksol Accord?
English: What is Pramipexole Accord?
Croatian: Što je Pramipeksol Accord?
English: What is Pramipexole Accord used for?
Croatian: Za što se Pramipeksol Accord koristi?
English: How has Pramipexole Accord been studied?
Croatian: Kako je Pramipeksol Accord ispitivan?
English: How is Pramipexole Accord used?
Croatian: Kako se Pramipeksol Accord koristi?
English: 20 mg/ml Oral drops, solution
Croatian: 20 mg/ml Oralne kapi, otopina bočica (staklo)
English: 10 mg tablet
Croatian: 10 mg tablete
English: MA (EU)-number
Croatian: Broj (EU) odobrenja
English: Perforated unit dose thermoformed blisters
Croatian: Termoformirani perforirani blister s jediničnim dozama
English: (invented) name Strength Pharmaceutical form
Croatian: Doza Farmaceutski oblik
English: Packsize
Croatian: Veličina pakovanja
English: As with all therapeutic proteins, there is a potential for immunogenicity.
Croatian: Kao i kod svih terapijskih proteina, postoji potencijal za imunogenost.
English: Talk to your doctor, pharmacist or nurse before using Zarzio.
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego primijenite Zarzio.
English: How long will I have to take Zarzio?
Croatian: Koliko dugo trebam uzimati Zarzio?
English: Zarzio is not recommended during pregnancy.
Croatian: Zarzio se ne preporučuje tijekom trudnoće.
English: Zarzio can be used:
Croatian: Zarzio se može primjenjivati:
English: How is Zarzio given and how much should I take?
Croatian: Kako se Zarzio daje i koju količinu trebam uzeti?
English: 10 6336 Langkampfen Austria
Croatian: 6336 Langkampfen
English: If you become pregnant during Zarzio treatment, please inform your doctor.
Croatian: Ako zatrudnite tijekom terapije lijekom Zarzio, obavijestite svog liječnika.
English: Your doctor will tell you how long you will need to take Zarzio.
Croatian: Vaš liječnik će Vam reći koliko dugo ćete trebati uzimati Zarzio.
English: What Zarzio looks like and contents of the pack
Croatian: Kako Zarzio izgleda i sadržaj pakiranja
English: Inject the Zarzio solution as you have been shown by your doctor.
Croatian: Ubrizgajte otopinu Zarzio kako Vam je pokazao liječnik.
English: Zarzio is usually given as a daily injection into the tissue just under the skin (known as a subcutaneous injection).
Croatian: Zarzio se obično daje kao dnevna injekcija u tkivo neposredno ispod kože (poznata kao potkožna injekcija).
English: Zarzio is provided with or without a needle safety guard and you will be shown how to use this by your doctor or nurse.
Croatian: Zarzio je dostupan sa ili bez sigurnosne zaštite za iglu i liječnik ili medicinska sestra će Vam pokazati kako da ga koristite.
English: Pharmacotherapeutic group: Immunostimulants, colony stimulating factors, ATC Code: L03AA02
Croatian: 5.1 Farmakodinamička svojstva Farmakoterapijska skupina: Imunostimulatori, čimbenici stimulacije kolonija, ATK oznaka: L03AA02
English: It is advisable to wait and see how you feel after taking Zarzio and before driving or operating machinery.
Croatian: Preporučuje se da pričekate kako biste vidjeli kako se osjećate nakon uzimanja lijeka Zarzio i prije upravljanja vozilom ili rada sa strojevima.
English: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Zarzio therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Croatian: Potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje/suzdržati se od liječenja lijekom Zarzio uzimajući u obzir korist dojenja za dijete i korist liječenja za ženu.
English: In order to improve the traceability of granulocyte-colony stimulating factors (G-CSFs), the trade name of the administered product should be clearly recorded in the patient file.
Croatian: Kako bi se poboljšala mogućnost praćenja čimbenika stimulacije granulocitnih kolonija (G-CSF), zaštićeni naziv primijenjenog lijeka treba jasno navesti u medicinskoj dokumentaciji bolesnika.
English: Unless your doctor directs you otherwise, you must stop breast feeding if you use Zarzio.
Croatian: Osim ako Vas liječnik ne uputi drugačije, morate prestati dojiti ako uzimate Zarzio.
English: Zarzio containing r-metHuG-CSF (filgrastim) causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes.
Croatian: Zarzio sadrži r-metHuG-CSF (filgrastim) koji uzrokuje izrazito povećanje broja neutrofila u perifernoj krvi u roku od 24 sata, uz manje povećanje broja monocita.
English: You will need to take Zarzio until your white blood cell count is normal.
Croatian: Zarzio ćete trebati uzimati sve dok Vam se broj bijelih krvnih stanica ne vrati na normalu.
English: Zarzio is available in packs containing 1, 3, 5 or 10 pre-filled syringes with injection needle and with or without a needle safety guard.
Croatian: Zarzio je dostupan u pakiranjima s 1, 3, 5 ili 10 napunjenih štrcaljki s iglom za injekciju, sa ili bez sigurnosne zaštite za iglu.
English: Zarzio is a white blood cell growth factor (granulocyte colony stimulating factor) and belongs to a group of proteins called cytokines.
Croatian: Zarzio je čimbenik rasta bijelih krvnih stanica (čimbenik stimulacije granulocitnih kolonija) i pripada skupini proteina koji se zovu citokini.
English: Other medicines and Zarzio
Croatian: Drugi lijekovi i Zarzio
English: In patients with HIV infection
Croatian: Kod bolesnika s HIV infekcijom
English: If you forget to use Zarzio
Croatian: Ako ste zaboravili primijeniti Zarzio
English: In view of the possible risk of microbial contamination, Zarzio syringes are for single use only.
Croatian: S obzirom na mogući rizik mikrobiološke kontaminacije, Zarzio štrcaljke su namijenjene samo za jednokratnu primjenu.
English: Zarzio is used to treat children who are receiving chemotherapy or who suffer from severe low white blood cell count (neutropenia).
Croatian: Zarzio se primjenjuje za liječenje djece koja primaju kemoterapiju ili boluju od teškog oblika sniženja broja bijelih krvnih stanica (neutropenije).
English: Randomised, double-blind, single and multiple dose, crossover studies in 204 healthy volunteers showed that the pharmacokinetic profile of Zarzio was comparable to that of the reference product after subcutaneous and intravenous administration.
Croatian: Randomizirana, dvostruko slijepa ukrižena ispitivanja primjene jednokratne i višekratnih doza u 204 zdravih dobrovoljaca pokazala su da se farmakokinetički profil lijeka Zarzio može usporediti s profilom referentnog lijeka nakon supkutane i intravenske primjene.
English: One retrospective European study evaluating the use of G-CSF after allogeneic bone marrow transplantation in patients with acute leukaemias suggested an increase in the risk of GvHD, treatment related mortality (TRM) and mortality when G-CSF was administered.
Croatian: Jedno retrospektivno europsko ispitivanje koje je procjenjivalo primjenu G-CSF nakon alogene transplantacije koštane srži u bolesnika s akutnim leukemijama ukazalo je na povećani rizik od GvHD, smrtnosti povezane s liječenjem (TRM) i smrtnosti kad se primjenjivao G-CSF.
English: If you develop or are likely to develop cancers of the blood, you should not use Zarzio unless instructed by your doctor.
Croatian: U slučaju razvoja ili vjerojatnog razvoja zloćudne bolesti krvi, Zarzio ne smijete primjenjivati osim ako Vam tako ne odredi liječnik.
English: Do not administer Zarzio to patients with a history of hypersensitivity to filgrastim or pegfilgrastim.
Croatian: Nemojte primjenjivati Zarzio bolesnicima s anamnezom preosjetljivosti na filgrastim ili pegfilgrastim.
English: Zarzio contains no preservative: In view of the possible risk of microbial contamination, Zarzio syringes are for single use only.
Croatian: Zarzio ne sadrži konzervanse: S obzirom na mogući rizik od mikrobiološke kontaminacije, štrcaljke
English: Zarzio contains sorbitol
Croatian: Zarzio sadrži sorbitol
English: Keep this medicine out of the sight and reach of children.
Croatian: Kako čuvati Zarzio Ovaj lijek čuvajte izvan pogleda i dohvata djece.
English: Zarzio is a biosimilar medicinal product.
Croatian: Zarzio je biosličan lijek.
English: Zarzio has not been tested in pregnant or breast-feeding women.
Croatian: Zarzio nije proučavan na trudnicama ili dojiljama.
English: Zarzio contains sorbitol (E420).
Croatian: Zarzio sadrži sorbitol (E420).
English: Zarzio contains no preservative.
Croatian: Zarzio ne sadrži konzervans.
English: What you need to know before you use Zarzio Do not use Zarzio
Croatian: Što morate znati prije nego počnete primjenjivati Zarzio
English: • if you get left upper belly (abdominal) pain, pain below the left rib cage or pain at the tip of your shoulder, as there may be a problem with your spleen [enlargement of the spleen (splenomegaly) or rupture of the spleen].
Croatian: • ako osjetite bolove u gornjoj lijevoj strani trbuha (abdomena), bol na lijevoj strani ispod rebara ili bol u vršku ramena, jer može postojati problem sa slezenom [povećanje slezene (splenomegalija) ili puknuće (ruptura) slezene].
English: Cutaneous vasculitisa Sweets syndrome (acute febrile neutrophilic dermatosis)
Croatian: Sweetov sindrom (akutna febrilna neutrofilna dermatoza)
English: If required, Zarzio may be diluted in glucose 50 mg/ml (5%) solution.
Croatian: Ukoliko je potrebno, Zarzio se može razrijediti u otopini glukoze50 mg/ml (5 %).
English: How to store Zarzio
Croatian: Kako primjenjivati Zarzio
English: Zarzio is a clear, colourless to slightly yellowish solution for injection or infusion in pre-filled syringe.
Croatian: Zarzio je bistra, bezbojna do svijetložuta otopina za injekciju ili infuziju u napunjenoj štrcaljki.
English: Zarzio is one of a group of products that stimulate the production of white blood cells.
Croatian: Zarzio je jedan iz skupine lijekova koji potiču proizvodnju bijelih krvnih stanica.
English: This section contains information on how to give yourself an injection of Zarzio.
Croatian: Upute kako da sami sebi date injekciju Ovaj dio sadrži informacije o tome kako da sami sebi date injekciju lijeka Zarzio.
English: What Zarzio is and what it is used for
Croatian: Što se nalazi u ovoj uputi: Što je Zarzio i za što se koristi
English: However, for a sustained therapeutic response, filgrastim therapy should not be discontinued before the expected nadir has passed and the neutrophil count has recovered to the normal range.
Croatian: Međutim, da bi se održao terapijski odgovor, terapija filgrastimom ne smije se prekinuti prije nego što se broj neutrofila nakon očekivanog smanjenja na najniže vrijednosti ne oporavi do normalnog raspona vrijednosti.
English: Accidental freezing will not harm Zarzio.
Croatian: Slučajno zamrzavanje neće naškoditi lijeku Zarzio.
English: Zarzio may have a minor influence on your ability to drive and use machines.
Croatian: Upravljanje vozilima i strojevima Zarzio može imati manji utjecaj na sposobnost upravljanja vozilima i rada sa strojevima.
English: Zarzio must not be diluted with sodium chloride solution.
Croatian: Zarzio se ne smije razrjeđivati otopinom natrijevog klorida.
English: In some cases, symptoms have recurred with rechallenge, suggesting a causal relationship.
Croatian: U nekim slučajevima simptomi su se ponavljali kod ponovnog izlaganja lijeku (rechallengea), što ukazuje na uzročno-posljedični odnos.
English: Zarzio stimulates the bone marrow to produce new white cells quickly.
Croatian: Zarzio stimulira koštanu srž da brže proizvodi nove bijele krvne stanice.
English: Zarzio must not be diluted with sodium chloride solutions.
Croatian: Zarzio se ne smije razrijediti otopinama natrijevog klorida.
English: • rejection of transplanted bone marrow (graft versus host disease)
Croatian: • odbacivanje transplantirane koštane srži (reakcija presatka protiv primatelja )
English: Your doctor will tell you how much Zarzio you should take.
Croatian: Vaš liječnik će Vam reći koju količinu lijeka Zarzio trebate uzeti.
English: Leukocytosis (WBC > 50 x 109/l) was observed in 41% of normal donors and transient thrombocytopenia (platelets < 100 x 109/l) following filgrastim and leukapheresis was observed in 35% of donors (see section 4.4).
Croatian: Leukocitoza (leukociti > 50 x 109/l) je primijećena u 41 % normalnih davatelja, dok je prolazna trombocitopenija (trombociti < 100 x 109/l) nakon filgrastima i leukafereze primijećena u 35 %
English: Permanently discontinue Zarzio in patients with clinically significant hypersensitivity.
Croatian: Trajno prekinite davanje lijeka Zarzio u bolesnika s klinički značajnom preosjetljivosti.
English: Zarzio works by encouraging the bone marrow to produce more white blood cells.
Croatian: Zarzio djeluje poticanjem koštane srži da proizvodi više bijelih krvnih stanica.